FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019410596> ?p ?o ?g. }

• W2019410596 endingPage "79" @default.
• W2019410596 startingPage "72" @default.
• W2019410596 abstract "Cocaine addiction is characterized by a persistently heightened susceptibility to drug relapse. For this reason, the identification of medications that prevent drug relapse is a critical goal of drug abuse research. Drug re-exposure, the onset of stressful life events, and exposure to cues previously associated with drug use have been identified as determinants of relapse in humans and have been found to reinstate extinguished cocaine seeking in rats. This study examined the effects of acute oral (gavage) administration of levo-tetrahydropalmatine (l-THP), a tetrahydroprotoberberine isoquinoline with a pharmacological profile that includes antagonism of D1, D2 and D3 dopamine receptors, on the reinstatement of extinguished cocaine seeking by a cocaine challenge (10 mg/kg, ip), a stressor (uncontrollable electric footshock [EFS]) or response-contingent exposure to a stimulus (tone and light complex) previously associated with drug delivery in male Sprague–Dawley rats. Extinguished drug seeking was reinstated by ip cocaine, EFS, or response-contingent presentation of drug-associated cues in vehicle-pretreated rats following extinction of iv cocaine self-adminisration. Oral administration of either 3.0 or 10.0 mg/kg l-THP 1 h prior to reinstatement testing significantly attenuated reinstatement by each of the stimuli. Food-reinforced responding and baseline post-extinction responding were significantly attenuated at the 10.0, but not the 3.0 mg/kg, l-THP dose, indicating that the effects of 3 mg/kg l-THP on reinstatement were likely independent of non-specific motor impairment. These findings further suggest that l-THP may have utility for the treatment of cocaine addiction." @default.
• W2019410596 created "2016-06-24" @default.
• W2019410596 creator A5000964272 @default.
• W2019410596 creator A5011772959 @default.
• W2019410596 creator A5017170080 @default.
• W2019410596 creator A5027062572 @default.
• W2019410596 creator A5029882097 @default.
• W2019410596 creator A5052906301 @default.
• W2019410596 creator A5077757829 @default.
• W2019410596 creator A5085973985 @default.
• W2019410596 creator A5089044431 @default.
• W2019410596 creator A5091237897 @default.
• W2019410596 date "2011-07-01" @default.
• W2019410596 modified "2023-09-26" @default.
• W2019410596 title "Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats" @default.
• W2019410596 cites W1766653312 @default.
• W2019410596 cites W1962727914 @default.
• W2019410596 cites W1964528322 @default.
• W2019410596 cites W1964739293 @default.
• W2019410596 cites W1966279706 @default.
• W2019410596 cites W1969789448 @default.
• W2019410596 cites W1974504536 @default.
• W2019410596 cites W1974681763 @default.
• W2019410596 cites W1976629371 @default.
• W2019410596 cites W1977678226 @default.
• W2019410596 cites W1978421807 @default.
• W2019410596 cites W1978686840 @default.
• W2019410596 cites W1980277133 @default.
• W2019410596 cites W1982436434 @default.
• W2019410596 cites W1983615230 @default.
• W2019410596 cites W1985557013 @default.
• W2019410596 cites W1987511461 @default.
• W2019410596 cites W1991370576 @default.
• W2019410596 cites W1993787748 @default.
• W2019410596 cites W1995006074 @default.
• W2019410596 cites W2000318092 @default.
• W2019410596 cites W2000769329 @default.
• W2019410596 cites W2003219097 @default.
• W2019410596 cites W2003301993 @default.
• W2019410596 cites W2006636385 @default.
• W2019410596 cites W2008477832 @default.
• W2019410596 cites W2012183787 @default.
• W2019410596 cites W2016209788 @default.
• W2019410596 cites W2016393906 @default.
• W2019410596 cites W2016658603 @default.
• W2019410596 cites W2018141098 @default.
• W2019410596 cites W2021541047 @default.
• W2019410596 cites W2029938675 @default.
• W2019410596 cites W2046028128 @default.
• W2019410596 cites W2046221597 @default.
• W2019410596 cites W2053030710 @default.
• W2019410596 cites W2055391686 @default.
• W2019410596 cites W2056711311 @default.
• W2019410596 cites W2062693848 @default.
• W2019410596 cites W2063288222 @default.
• W2019410596 cites W2074607412 @default.
• W2019410596 cites W2074615095 @default.
• W2019410596 cites W2078672024 @default.
• W2019410596 cites W2079062881 @default.
• W2019410596 cites W2080245329 @default.
• W2019410596 cites W2080725690 @default.
• W2019410596 cites W2093670721 @default.
• W2019410596 cites W2093757762 @default.
• W2019410596 cites W2095219741 @default.
• W2019410596 cites W2098304576 @default.
• W2019410596 cites W2117864279 @default.
• W2019410596 cites W2128086091 @default.
• W2019410596 cites W2130332398 @default.
• W2019410596 cites W2140159910 @default.
• W2019410596 cites W2142231236 @default.
• W2019410596 cites W2148455827 @default.
• W2019410596 cites W2154850432 @default.
• W2019410596 cites W2168154818 @default.
• W2019410596 cites W2171282854 @default.
• W2019410596 cites W2322589228 @default.
• W2019410596 cites W2328414509 @default.
• W2019410596 doi "https://doi.org/10.1016/j.drugalcdep.2010.11.023" @default.
• W2019410596 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3466100" @default.
• W2019410596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21196089" @default.
• W2019410596 hasPublicationYear "2011" @default.
• W2019410596 type Work @default.
• W2019410596 sameAs 2019410596 @default.
• W2019410596 citedByCount "45" @default.
• W2019410596 countsByYear W20194105962012 @default.
• W2019410596 countsByYear W20194105962013 @default.
• W2019410596 countsByYear W20194105962014 @default.
• W2019410596 countsByYear W20194105962015 @default.
• W2019410596 countsByYear W20194105962016 @default.
• W2019410596 countsByYear W20194105962017 @default.
• W2019410596 countsByYear W20194105962018 @default.
• W2019410596 countsByYear W20194105962019 @default.
• W2019410596 countsByYear W20194105962020 @default.
• W2019410596 countsByYear W20194105962021 @default.
• W2019410596 countsByYear W20194105962022 @default.
• W2019410596 countsByYear W20194105962023 @default.
• W2019410596 crossrefType "journal-article" @default.
• W2019410596 hasAuthorship W2019410596A5000964272 @default.
• W2019410596 hasAuthorship W2019410596A5011772959 @default.

• next